Table of contents
November 2002 Vol 1 No 11
In This Issue
p835 | doi:10.1038/nrd950
Editorial: Interdisciplinary equilibrium
p837 | doi:10.1038/nrd958
Research Highlights
Analgesics: Time for a new COX?
p839 | doi:10.1038/nrd951
Cardiovascular disease: Macrophage LXRs inhibit atherosclerosis
p840 | doi:10.1038/nrd946
Autoimmune disease: Lesions with a jagged edge
p840 | doi:10.1038/nrd949
Lead generation: Alternative route
p841 | doi:10.1038/nrd945
Anticoagulants: Balance control
p842 | doi:10.1038/nrd947
Biotechnology: Turn it off
p842 | doi:10.1038/nrd948
Structure-based drug design: Complex is crystal clear
p842 | doi:10.1038/nrd952
Protein structure: Folding forecast
p843 | doi:10.1038/nrd953
In brief
Anticancer drugs | G-protein-coupled receptors | Nanotechnology | Anticaner drugs
p843 | doi:10.1038/nrd954
News and Analysis
Patent watch
Augmentin' the battle | Anticipating transgenic mice
p844 | doi:10.1038/nrd955
From the analyst's couch
The evolution of biotech
p845 | doi:10.1038/nrd944
Career focus
Easing the chemistry bottleneck: careers in high-throughput chemistry
p925 | doi:10.1038/nrd957
Reviews
Designing peptide receptor agonists and antagonists
Victor J. Hruby
p847 | doi:10.1038/nrd939
Therapeutic strategies for Alzheimer's disease
Michael S. Wolfe
p859 | doi:10.1038/nrd938
Hepatitis C therapeutics: current status and emerging strategies
Seng-Lai Tan, Arnim Pause, Yuguang Shi & Nahum Sonenberg
p867 | doi:10.1038/nrd937
Integration of virtual and high-throughput screening
Jürgen Bajorath
p882 | doi:10.1038/nrd941
The future challenges facing the development of new antimicrobial drugs
Anthony Coates, Yanmin Hu, Richard Bax & Clive Page
p895 | doi:10.1038/nrd940
Perspectives
Innovation
Hepatitis C virus replicons: potential role for drug development
Ralf Bartenschlager
p911 | doi:10.1038/nrd942
Outlook
Drug advertising: the right or wrong prescription for our ailments?
Mollyann Brodie & Larry Levitt
p916 | doi:10.1038/nrd943
Correction: Pharmacotherapy of addictions
Mary Jeanne Kreek, K. Steven LaForge & Eduardo Butelman
p926 | doi:10.1038/nrd968
